logo
logo

Nocion Therapeutics Appoints Matthew Frankel As Chief Medical Officer

Apr 28, 2025•3 months ago

Position

Chief Medical Officer

Company

Nocion Therapeutics

Matthew Frankel
WalthamBiotechnology

Description

Nocion Therapeutics, Inc. has appointed Matthew Frankel, M.D., MBA as Chief Medical Officer. Matthew brings valuable expertise to advance the clinical development of Taplucainium for chronic cough.

Company Information

Company

Nocion Therapeutics

Location

Waltham, Massachusetts, United States

About

Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons including chronic cough, pain and itch.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months